Financial Statements — BLRX
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 7.19 | 9.62 | 10.10 | 14.00 | 17.48 |
| Inventory | 2.85 | 3.63 | -- | -- | -- |
| Total Current Assets | 31.86 | 49.11 | 34.69 | 44.10 | 67.07 |
| Total Non-current Assets | 11.41 | 15.49 | 24.24 | 23.74 | 24.26 |
| Total Assets | 43.27 | 64.60 | 58.94 | 67.84 | 91.33 |
| Total Current Liabilities | 15.48 | 30.52 | 12.45 | 9.63 | 9.92 |
| Total Non-current Liabilities | 7.72 | 20.10 | 25.44 | 1.64 | 7.52 |
| Total Liabilities | 23.20 | 50.62 | 37.88 | 11.27 | 17.44 |
| Retained Earnings | (398.64) | (390.82) | (360.70) | (317.41) | (295.02) |
| Total Stockholder Equity | 20.07 | 13.98 | 21.05 | 56.57 | 73.89 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 0.30 | 5.39 | -- | -- | -- |
| Cost of Revenue* | 0.07 | 0.90 | -- | -- | -- |
| Gross Profit | 0.23 | 4.50 | -- | -- | -- |
| Research & Development | 2.33 | 2.23 | 3.01 | 5.40 | 5.14 |
| Selling, General & Admin | 0.21 | 1.63 | 1.31 | 1.05 | 1.04 |
| Total Operating Expenses* | 2.54 | 10.27 | -- | -- | -- |
| Operating Income | (2.30) | (5.77) | (9.91) | (7.60) | (6.51) |
| Net Income | (3.94) | 0.48 | (18.55) | (7.44) | (6.84) |
| Basic EPS | 0.00 | 0.00 | (0.02) | (0.01) | -- |
| Diluted EPS | 0.00 | 0.00 | (0.02) | (0.01) | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (2.77) | (25.44) | (17.70) | (11.87) | (13.06) |
| Investing Cash Flow | (11.88) | 8.04 | 17.74 | 15.08 | (42.26) |
| Financing Cash Flow | 11.05 | 22.99 | (0.18) | (1.63) | 56.00 |
